Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

81.50
-1.4400-1.74%
Post-market: 81.500.00000.00%19:30 EDT
Volume:1.74M
Turnover:143.16M
Market Cap:15.96B
PE:-22.84
High:83.37
Open:82.89
Low:81.36
Close:82.94
52wk High:93.42
52wk Low:46.81
Shares:195.81M
Float Shares:154.00M
Volume Ratio:0.63
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-6.34
PE(LYR):-21.53

Loading ...

Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2026

Major Issues Report

Form 8-K - Current report
Jan 21, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 27, 2025

Major Issues Report

Form 8-K - Current report
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities